🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
This is a study to evaluate the clinical activity of the combination of flu...
Status
Active Not Recruiting
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Start Date
2019-07-29
Trial ID
NCT04005339
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
RATIONALE: Providing information that is tailored to answer patients' quest...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2008-04
Trial ID
NCT00750009
Treatments Being Tested
Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-01-01
Trial ID
NCT04767009
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
1998-03
Trial ID
NCT00003192
Treatments Being Tested
To determine the efficacy of iv sildenafil in term and near term infants wi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01360671
Treatments Being Tested
Ceftaroline fosamil is an intravenous (IV) drug that belongs to a group of ...
Status
Unknown
Location
Children's Hospital of Michigan
Start Date
2016-08
Trial ID
NCT02600793
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
To learn if the drug combination of tiragolumab and ivonescimab can help to...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-07-28
Trial ID
NCT07038915
Treatments Being Tested